Share this:
|
Issue 25 • August 2024 PMI Grants Team
| |
| Changes Coming to NIH Applications and Peer Review in 2025
These changes include updates to the peer review and submission of most research project grants, fellowships, and training grants; common forms for NIH biographical sketch and current and pending (other) support; updated instructions for reference letters; and the transition to FORMS-I application instructions. Although each of these initiatives has specific goals, they are all meant to simplify, clarify, and/or promote greater fairness towards a level playing field for applicants throughout the application and review process. View...
Tips for applicants
- Verify whether the activity code for your target funding opportunity is impacted and identify your target due date.
- If your activity code is impacted by the new framework and your target due date is on or after January 25, 2025, pay extra attention to the opportunity you use to apply.
| | | |
| NIAID Financial Management Plan
Competing investigator-initiated awards will be funded at 90 percent of approved funding level with start dates reset by one month. This excludes fellowship (F), training (T), career development (K), and small business (SBIR/STTR) awards, and awards funded with non-direct appropriations (e.g., emergency supplemental COVID appropriations), which will be funded with no reduction to the approved funding level. NIAID
| | | |
| NCI Funding Policy
NCI will generally fund both categorical and SNAP non-competing grants at 95% of the committed level. This policy applies to all grants, with the exception of the NRSAs, Career, Cancer Education, Continuing Education, P30 Cancer Centers, Conference, AIDS related grants, International Research Training Grants, Small Grants, Research Specialist, Pathway to Independence, SBIR, and STTR awards, which will be funded at committed levels. Non-competing grants that were awarded under the continuing resolution policy will be revised accordingly. NCI
| | | |
| NIH Data Management (DMS) & Sharing Plan
The NIH Data Management & Sharing DMS Policy applies to all research, funded or conducted in whole or in part by NIH, that results in the generation of scientific data.
Under the DMS policy, NIH expects that investigators and institutions:
- Plan and budget for the managing and sharing of data
- Submit a DMS plan for review when applying for funding
- Comply with the approved DMS plan
| |
| Additional information is available via the following links:
| | | |
|
Planning a proposal submission in the next 2 - 3 months? In an effort to better serve you, the PMI grants team requests that PIs and Fellows notify us as far in advance as possible of submission plans. This ensures ample time to complete departmental requirements and also route to OSP for review by their deadline. Here is the link to the new SRS intake tool for new/resubmission requests: View...
| | | |
| Missing PMCIDs and other common errors on proposals
The PMI grants team encourages applicants to review items often overlooked for compliance on NIH proposals. View...
| |
Just-In-Time (JIT)
When do you need to submit a JIT for NIH and how does it work? Click here for detailed information about NIH's Just-in-Time mechanism and PMI JIT policy.
| |
Funding Opportunities by Agency
American Cancer Society
Discovery Boost Grants (DBG) high-risk, high-reward exploratory cancer research. Awards are for up to 2 years with $135,000 a year for direct costs, plus 10% allowable indirect costs. Next submission deadlines: 10/15/24 and 04/01/25.
Mission Boost Grants (MBG) Stage I Mission Boost: $135,000/year for two years direct costs, plus 10% indirect costs. Stage II Mission Boost: Applicants may propose up to 18 months and $545,000 for direct costs, plus 10% indirect costs. Next submission deadlines: 10/15/24 and 04/01/25.
Research Scholar Grants Awards are for up to 4 years with up to $215,000/year for direct costs, plus 10% allowable indirect costs. Next submission deadlines: 10/15/24 and 04/01/25.
Postdoctoral Fellowship $66,000 Yr 1, $68,000 Yr 2, $70,0000 Yr 3, and additional $4,000/year Fellowship allowance. Next submission deadlines: 10/15/24 and 04/01/25.
American Heart Association
2025 Innovative Project Award $100,000/year including 10% indrects for two years. Pre-proposal due 12/05/24. Full application by invitation: 03/06/25.
Crohn's & Colitis Foundation
Senior Research Awards up to $118,182 per year, 10% indirect costs. Duration of award is one to three years. LOI: 11/15/24. Full application: 01/24/25.
Litwin IBD Pioneers $130,000 including 10% indirects for clinical trials; and up to $110,000 including 10% indirects for lab-based studies. Up to two years. LOI: 11/15/24. Full application: 01/24/25.
Career Development Awards Award salary will match applicants’ institutional salary (salaries may be supplemented by the applicant’s institution), depending on postgraduate year (PGY) level, up to $60,000 per year and fringe - up to $15,000 per year, plus $27,500 for non-salary/fringe expenses. LOI: 11/15/24. Full application: 01/24/25.
Research Fellowship Awards Maximum award per year: $70,000 for one to three years including salary, fringe, and non-salary/fringe expenses. LOI: 11/15/24. Full application: 01/24/25.
Damon Runyon Cancer Research Foundation
Damon Runyon Physician-Scientist Training Award Award period is four years, total award: $460,000. Additionally, The Damon Runyon Cancer Research Foundation will retire up to $100,000 of any qualifying medical school debt still owed by the awardee. Applications due by 12/02/24.
Damon Runyon Clinical Investigator Award $200,000/year for three years. The Damon Runyon Cancer Research Foundation will retire up to $100,000 of any qualifying medical school debt still owed by the awardee. Applications due 02/03/25.
Damon Runyon Fellowship Award Stipend: $70,000 Yr 1, $72,000 Yr 2, $74,000, Yr 3, and $76,000 Yr 4 plus 2K/year expense allowance. The Damon Runyon Cancer Research Foundation will retire up to $100,000 of any qualifying medical school debt still owed by the awardee. Applications due by 03/15/25
Patient-Centered Outcomes Research Institute (PCORI)
- Category 1 will support research projects with direct costs up to and including $5 million.
- Category 2 will support research projects with direct costs greater than $5 million and up to a maximum of $10 million.
- Category 3 will support research projects with direct costs up to $10 million that utilize PCORnet® to conduct observational studies and/or pragmatic trials that are national in scale.
Funding awards under this PFA are expected to be announced in November 2024.
| | | |
|
NIH Standard Deadlines
October
R01 (New) Routing: 09/25/24, Sponsor: 10/05/24
U01 (New) Routing: 09/25/24, Sponsor: 10/05/24
K Series (New) Routing: 10/02/24, Sponsor: 10/12/24
R21 (New) Routing: 10/04/24, Sponsor: 10/16/24
November
R01 (Renewal, Resubmission, Revision) Routing: 10/24/24, Sponsor: 11/05/24
U01 (Renewal, Resubmission, Revision) Routing: 10/24/24, Sponsor: 11/05/24
K Series (New) Routing: 10/31/24, Sponsor: 11/12/24
R21 (New) Routing: 11/05/24, Sponsor: 11/16/24
December
F series (New, Renewal, Resubmission) Routing: 11/26/24, Sponsor: 12/08/24
R13, U13 (New, Renewal, Resubmission, Revision) Routing: 12/02/24, Sponsor: 12/12/24
January
P Series (New, Renewal, Resubmission, Revision) Routing: 01/14/25, Sponsor: 01/25/25
R18, U18, R25 (New, Renewal, Resubmission, Revision) Routing: 01/14/25, Sponsor: 01/25/25
T & D Series (New, Renewal, Resubmission, Revision) Routing: 01/14/25, Sponsor: 01/25/25
C06/UC6
(New, Renewal, Resubmission, Revision) Routing: 01/14/25, Sponsor: 01/25/25
February
R01 (New) Routing: 01/24/25, Sponsor: 02/05/25
U01 (New) Routing: 01/24/25, Sponsor: 02/05/25
K Series (New) Routing: 01/31/25, Sponsor: 02/12/25
R21 (New) Routing: 02/04/25, Sponsor: 02/16/25
| |
|
Additional Funding Opportunities:
NOT-OD-23-032 Notice of Special Interest (NOSI): Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards Up to 70K. Deadlines vary by awarding IC.
PAR-24-075 Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed) Application budgets are not limited but need to reflect the actual needs of the proposed project. Next due dates: 09/26/24 and 01/28/25
PAR-23-145 Maximizing Investigators’ Research Award (MIRA) for Early Stage Investigators (ESI) (R35 - Clinical Trial Optional) up to $250,000 direct costs/year. Next due dates: 10/03/24 and 02/03/25.
PAR-23-275 NIAID and NIDDK Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional) Application budgets are not limited but need to reflect the actual needs of the proposed project. Next due dates: 10/05/24 and 02/05/25. Next AIDS deadline: 01/07/25.
PA-24-194 NIH Pathway to Independence Award (Parent K99/R00 – Independent Clinical Trial Not Allowed) Salary and research costs may be requested to the level provided by the awarding Institute or Center plus indirects. Next due dates: 10/12/24 and 02/12/25.
PAR-24-225 Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed) Salary and research costs may be requested to the level provided by the awarding Institute or Center plus indirects. Next due dates: 10/12/24 and 02/12/25.
PAR-23-056 Co-infection and Cancer (R21 Clinical Trial Not Allowed) The combined budget for direct costs for the two-year project period may not exceed $275,000 Next due dates: 10/16/24 and 02/16/25.
PAR-23-055 Co-infection and Cancer (R01 Clinical Trial Not Allowed) Application budgets are not limited but need to reflect the actual needs of the proposed project. Earliest submission dates for new applications: 10/05/24 and 02/05/25.
PAR-24-037 HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed) Up to $2,500,000 directs/year. LOI: 30 days prior to application deadline. Due: 03/13/25.
PAR-23-024 Catalyst Award for Early-Stage Investigators (ESIs) Pursuing Research on HIV Comorbidities, Coinfections, and Complications (DP1- Clinical Trial Optional) Direct costs are limited to $350,000 per year. Due 05/01/25.
PAR-23-246 Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed) Up to $475,000 in direct costs/year. Next due dates: 11/04/24 and 05/05/25.
PAR-23-139 CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Translational Exploratory/Developmental Research Projects (R21 Clinical Trial Not Allowed) direct costs for the two-year project period may not exceed $275,000. Due: 05/30/25.
| |
|
Have a pressing inquiry regarding submissions or post-award items? We're here to help! Candice Stevens, Associate Director, Lauren Milam, Sr Financial Manager, Edith Ashcraft, Sr Financial Analyst, Doug Smith, Sr Financial Analyst, Leigh Thompson, Budget Accounting Analyst Post-Award, Karin Sack, Grants Manager, and Alethea Kelly, Grants Manager.
| |
|
|
|
|
Vanderbilt University Medical Center 1161 21st Ave S | Nashville, TN 37232 US
|
|
